Your browser doesn't support javascript.
loading
Phase I/II Trial of a Combination of Anti-CD3/CD7 Immunotoxins for Steroid-Refractory Acute Graft-versus-Host Disease.
Groth, Christoph; van Groningen, Lenneke F J; Matos, Tiago R; Bremmers, Manita E; Preijers, Frank W M B; Dolstra, Harry; Reicherts, Christian; Schaap, Nicolaas P M; van Hooren, Eric H G; IntHout, Joanna; Masereeuw, Rosalinde; Netea, Mihai G; Levine, John E; Morales, George; Ferrara, James L; Blijlevens, Nicole M A; van Oosterhout, Ypke V J M; Stelljes, Matthias; van der Velden, Walter J F M.
Afiliación
  • Groth C; Department of Medicine A/Hematology and Oncology, University Hospital of Muenster, Muenster, Germany.
  • van Groningen LFJ; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Matos TR; Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Bremmers ME; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Preijers FWMB; Department of Laboratory Medicine, Laboratory for Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Dolstra H; Department of Laboratory Medicine, Laboratory for Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Reicherts C; Department of Medicine A/Hematology and Oncology, University Hospital of Muenster, Muenster, Germany.
  • Schaap NPM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Hooren EHG; Xenikos B.V., Nijmegen, The Netherlands.
  • IntHout J; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands; Section of Biostatistics, Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Masereeuw R; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
  • Netea MG; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Levine JE; Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, New York, NY.
  • Morales G; Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, New York, NY.
  • Ferrara JL; Tisch Cancer Institute, The Icahn School of Medicine at Mount Sinai Hospital, New York, NY.
  • Blijlevens NMA; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Oosterhout YVJM; Xenikos B.V., Nijmegen, The Netherlands.
  • Stelljes M; Department of Medicine A/Hematology and Oncology, University Hospital of Muenster, Muenster, Germany.
  • van der Velden WJFM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands; Radboud Institute of Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Walter.vanderVelden@radboudumc.nl.
Biol Blood Marrow Transplant ; 25(4): 712-719, 2019 04.
Article en En | MEDLINE | ID: mdl-30399420
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunotoxinas / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunotoxinas / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos